Previous studies reported that IGFBP5 modulated pancreatic cancer cell growth and survival through the MAPK or PI3K pathway, and promoted prostate cancer growth via activating the PI3K pathway 16, 17. Here, IGFBP5 is linked to pancreatic neoplasm.